Genome-wide association study identifies multiple susceptibility loci for glioma

Nature Communications

Volumn 6, Issue , 2015, Pages

  Kinnersley, Ben ^a   Labussière, Marianne ^b   Holroyd, Amy ^a   Di Stefano, Anna Luisa ^b,c,d   Broderick, Peter ^a   Vijayakrishnan, Jayaram ^a   Mokhtari, Karima ^b,c,d   Delattre, Jean Yves ^b,c,d   Gousias, Konstantinos ^e   Schramm, Johannes ^e   Schoemaker, Minouk J ^a   Fleming, Sarah J ^f   Herms, Stefan ^g,h   Heilmann, Stefanie ^g   Schreiber, Stefan ^i,j   Wichmann, Heinz Erich ^k,l   Nöthen, Markus M ^g   Swerdlow, Anthony ^a   Lathrop, Mark ^d,m,n   Simon, Matthias ^e   Bondy, Melissa ^o   Sanson, Marc ^b,c,d   Houlston, Richard S ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b SORBONNE UNIVERSITÉ   (France)

^c Onconeurotek   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY OF BASEL   (Switzerland)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j UNIVERSITY OF KIEL   (Germany)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

^l UNIVERSITY OF MUNICH   (Germany)

^m FONDATION JEAN DAUSSET CEPH   (France)

ⁿ MCGILL UNIVERSITY   (Canada)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENETIC VARIATION; GENOME; GENOTYPE; HERITABILITY; IDENTIFICATION METHOD; MOLECULAR ANALYSIS; NERVOUS SYSTEM DISORDER; RISK ASSESSMENT; TUMOR; VULNERABILITY;

ADULT; ARTICLE; CHROMATIN; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; META ANALYSIS; MIDDLE AGED;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLIOMA; HUMANS; MALE; MIDDLE AGED;

EID: 84943145966     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9559     Document Type: Article

References (70)

1. Bondy, M. L. et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113, 1953-1968 (2008).
2. Louis, D. N. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114, 97-109 (2007).
3. Ostrom, Q. T. et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 16, 896-913 (2014).
4. Hodgson, S. V., Maher, E. R. & Hodgson, S. A Practical Guide to Human Cancer Genetics (Springer, 1999).
5. Hemminki, K., Tretli, S., Sundquist, J., Johannesen, T. B. & Granstrom, C. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol. 10, 481-488 (2009).
6. Sanson, M. et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum. Mol. Genet. 20, 2897-2904 (2011).
7. Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41, 899-904 (2009).
8. Wrensch, M. et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41, 905-908 (2009).
9. Enciso-Mora, V. et al. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br. J. Cancer 108, 2178-2185 (2013).
10. Walsh, K. M. et al. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat. Genet. 46, 731-735 (2014).
11. Enciso-Mora, V. et al. Deciphering the 8q24.21 association for glioma. Hum. Mol. Genet. 22, 2293-2302 (2013).
12. Huang, J. et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat. Commun. 6, 8111 (2015).
13. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
14. Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934-947 (2013).
15. Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455-461 (2014).
16. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506-511 (2013).
17. Grundberg, E. et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
18. Westra, H. J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).
19. Pharoah, P. D., Antoniou, A. C., Easton, D. F. & Ponder, B. A. Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358, 2796-2803 (2008).
20. Bose, A. et al. The v-SNARE Vti1a regulates insulin-stimulated glucose transport and Acrp30 secretion in 3T3-L1 adipocytes. J. Biol. Chem. 280, 36946-36951 (2005).
21. Ramirez, D. M., Khvotchev, M., Trauterman, B. & Kavalali, E. T. Vti1a identifies a vesicle pool that preferentially recycles at rest and maintains spontaneous neurotransmission. Neuron 73, 121-134 (2012).
22. Lan, Q. et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat. Genet. 44, 1330-1335 (2012).
23. Wang, H. et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat. Commun. 5, 4613 (2014).
24. Chen, S. J. et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91, 2260-2267 (1993).
25. Ahmad, K. F., Engel, C. K. & Prive, G. G. Crystal structure of the BTB domain from PLZF. Proc. Natl Acad. Sci. USA 95, 12123-12128 (1998).
26. Vallee, R. B., Varma, D. & Dujardin, D. L. ZW10 function in mitotic checkpoint control, dynein targeting, and membrane trafficking: is dynein the unifying theme? Cell Cycle 5, 2447-2451 (2014).
27. Frerman, F. E. Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase. Biochem. Soc. Trans. 16, 416-418 (1988).
28. Indo, Y., Glassberg, R., Yokota, I. & Tanaka, K. Molecular characterization of variant alpha-subunit of electron transfer flavoprotein in three patients with glutaric acidemia type II-and identification of glycine substitution for valine-157 in the sequence of the precursor, producing an unstable mature protein in a patient. Am. J. Hum. Genet. 49, 575-580 (1991).
29. Freneaux, E., Sheffield, V. C., Molin, L., Shires, A. & Rhead, W. J. Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients. J. Clin. Invest. 90, 1679-1686 (1992).
30. Bross, P. et al. A polymorphic variant in the human electron transfer flavoprotein a-chain (a-T171) displays decreased thermal stability and is overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient patients with mild childhood presentation. Mol. Genet. Metab. 67, 138-147 (1999).
31. Dieci, G., Fiorino, G., Castelnuovo, M., Teichmann, M. & Pagano, A. The expanding RNA polymerase III transcriptome. Trends Genet. 23, 614-622 (2007).
32. Saitsu, H. et al. Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am. J. Hum. Genet. 89, 644-651 (2011).
33. Johnson, E. O. et al. PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. J. Cell Sci. 124, 2711-2722 (2011).
34. Sellheyer, K., Nelson, P., Kutzner, H. & Patel, R. M. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. J. Cutan. Pathol. 40, 363-370 (2013).
35. Cardis, E. et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur. J. Epidemiol. 22, 647-664 (2007).
36. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
37. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007).
38. Hercberg, S. et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch. Intern. Med. 164, 2335-2342 (2004).
39. Wichmann, H. E., Gieger, C. & Illig, T.MONICA/KORA Study Group. KORAgen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67(Suppl 1): S26-S30 (2005).
40. Krawczak, M. et al. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 9, 55-61 (2006).
41. Schmermund, A. et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am. Heart J. 144, 212-218 (2002).
42. Penegar, S. et al. National study of colorectal cancer genetics. Br. J. Cancer 97, 1305-1309 (2007).
43. Eisen, T., Matakidou, A., Houlston, R. & Consortium, G. Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer 8, 244 (2008).
44. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
45. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
46. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).
47. Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
48. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005).
49. Liu, J. Z. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42, 436-440 (2010).
50. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557-560 (2003).
51. Scheurer, M. E. et al. Familial aggregation of glioma: a pooled analysis. Am. J. Epidemiol. 172, 1099-1107 (2010).
52. Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156-2158 (2011).
53. Scales, M., Jager, R., Migliorini, G., Houlston, R. S. & Henrion, M. Y. visPIG - a web tool for producing multi-region, multi-track, multi-scale plots of genetic data. PLoS ONE 9, e107497 (2014).
54. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
55. Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
56. Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
57. Ng, S. B. et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461, 272-276 (2009).
58. de Souza, N. The ENCODE project. Nat. Methods 9, 1046 (2012).
59. Cooper, G. M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15, 901-913 (2005).
60. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
61. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
62. Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
63. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
64. Zhang, K., Cui, S., Chang, S., Zhang, L. & Wang, J. i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res. 38, W90-W95 (2010).
65. Idbaih, A. et al. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int. J. Cancer 122, 1778-1786 (2008).
66. Gonzalez-Aguilar, A. et al. Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. Clin. Cancer Res. 18, 5203-5211 (2012).
67. Sanson, M. et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J. Clin. Oncol. 27, 4150-4154 (2009).
68. Labussiere, M. et al. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br. J. Cancer 111, 2024-2032 (2014).
69. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
70. Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).